Global Immuno Oncology Assays Market Growth (Status and Outlook) 2025-2031

September 2025 | 70 pages | ID: GCC043F43D7EN
LP Information

Abstracts

According to this study, the global Immuno Oncology Assays market size will reach US$ 11220 million by 2031.

Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).

United States market for Immuno Oncology Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Immuno Oncology Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Immuno Oncology Assays is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Immuno Oncology Assays players cover Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies, Illumina, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Immuno Oncology Assays Industry Forecast” looks at past sales and reviews total world Immuno Oncology Assays sales in 2024, providing a comprehensive analysis by region and market sector of projected Immuno Oncology Assays sales for 2025 through 2031. With Immuno Oncology Assays sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immuno Oncology Assays industry.

This Insight Report provides a comprehensive analysis of the global Immuno Oncology Assays landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Immuno Oncology Assays portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Immuno Oncology Assays market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immuno Oncology Assays and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immuno Oncology Assays.

This report presents a comprehensive overview, market shares, and growth opportunities of Immuno Oncology Assays market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Immunoassay
• Flow Cytometry
• PCR
• Next Generation Sequencing

Segmentation by Application:

• Research
• Clinical Diagnostics

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Thermo Fischer Scientific
• Roche Diagnostics
• Agilent Technologies
• Illumina

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Immuno Oncology Assays Market Size (2020-2031)
  2.1.2 Immuno Oncology Assays Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Immuno Oncology Assays by Country/Region (2020, 2024 & 2031)
2.2 Immuno Oncology Assays Segment by Type
  2.2.1 Immunoassay
  2.2.2 Flow Cytometry
  2.2.3 PCR
  2.2.4 Next Generation Sequencing
2.3 Immuno Oncology Assays Market Size by Type
  2.3.1 Immuno Oncology Assays Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Immuno Oncology Assays Market Size Market Share by Type (2020-2025)
2.4 Immuno Oncology Assays Segment by Application
  2.4.1 Research
  2.4.2 Clinical Diagnostics
2.5 Immuno Oncology Assays Market Size by Application
  2.5.1 Immuno Oncology Assays Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Immuno Oncology Assays Market Size Market Share by Application (2020-2025)

3 IMMUNO ONCOLOGY ASSAYS MARKET SIZE BY PLAYER

3.1 Immuno Oncology Assays Market Size Market Share by Player
  3.1.1 Global Immuno Oncology Assays Revenue by Player (2020-2025)
  3.1.2 Global Immuno Oncology Assays Revenue Market Share by Player (2020-2025)
3.2 Global Immuno Oncology Assays Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 IMMUNO ONCOLOGY ASSAYS BY REGION

4.1 Immuno Oncology Assays Market Size by Region (2020-2025)
4.2 Global Immuno Oncology Assays Annual Revenue by Country/Region (2020-2025)
4.3 Americas Immuno Oncology Assays Market Size Growth (2020-2025)
4.4 APAC Immuno Oncology Assays Market Size Growth (2020-2025)
4.5 Europe Immuno Oncology Assays Market Size Growth (2020-2025)
4.6 Middle East & Africa Immuno Oncology Assays Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Immuno Oncology Assays Market Size by Country (2020-2025)
5.2 Americas Immuno Oncology Assays Market Size by Type (2020-2025)
5.3 Americas Immuno Oncology Assays Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Immuno Oncology Assays Market Size by Region (2020-2025)
6.2 APAC Immuno Oncology Assays Market Size by Type (2020-2025)
6.3 APAC Immuno Oncology Assays Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Immuno Oncology Assays Market Size by Country (2020-2025)
7.2 Europe Immuno Oncology Assays Market Size by Type (2020-2025)
7.3 Europe Immuno Oncology Assays Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Immuno Oncology Assays by Region (2020-2025)
8.2 Middle East & Africa Immuno Oncology Assays Market Size by Type (2020-2025)
8.3 Middle East & Africa Immuno Oncology Assays Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET FORECAST

10.1 Global Immuno Oncology Assays Forecast by Region (2026-2031)
  10.1.1 Global Immuno Oncology Assays Forecast by Region (2026-2031)
  10.1.2 Americas Immuno Oncology Assays Forecast
  10.1.3 APAC Immuno Oncology Assays Forecast
  10.1.4 Europe Immuno Oncology Assays Forecast
  10.1.5 Middle East & Africa Immuno Oncology Assays Forecast
10.2 Americas Immuno Oncology Assays Forecast by Country (2026-2031)
  10.2.1 United States Market Immuno Oncology Assays Forecast
  10.2.2 Canada Market Immuno Oncology Assays Forecast
  10.2.3 Mexico Market Immuno Oncology Assays Forecast
  10.2.4 Brazil Market Immuno Oncology Assays Forecast
10.3 APAC Immuno Oncology Assays Forecast by Region (2026-2031)
  10.3.1 China Immuno Oncology Assays Market Forecast
  10.3.2 Japan Market Immuno Oncology Assays Forecast
  10.3.3 Korea Market Immuno Oncology Assays Forecast
  10.3.4 Southeast Asia Market Immuno Oncology Assays Forecast
  10.3.5 India Market Immuno Oncology Assays Forecast
  10.3.6 Australia Market Immuno Oncology Assays Forecast
10.4 Europe Immuno Oncology Assays Forecast by Country (2026-2031)
  10.4.1 Germany Market Immuno Oncology Assays Forecast
  10.4.2 France Market Immuno Oncology Assays Forecast
  10.4.3 UK Market Immuno Oncology Assays Forecast
  10.4.4 Italy Market Immuno Oncology Assays Forecast
  10.4.5 Russia Market Immuno Oncology Assays Forecast
10.5 Middle East & Africa Immuno Oncology Assays Forecast by Region (2026-2031)
  10.5.1 Egypt Market Immuno Oncology Assays Forecast
  10.5.2 South Africa Market Immuno Oncology Assays Forecast
  10.5.3 Israel Market Immuno Oncology Assays Forecast
  10.5.4 Turkey Market Immuno Oncology Assays Forecast
10.6 Global Immuno Oncology Assays Forecast by Type (2026-2031)
10.7 Global Immuno Oncology Assays Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Immuno Oncology Assays Forecast

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fischer Scientific
  11.1.1 Thermo Fischer Scientific Company Information
  11.1.2 Thermo Fischer Scientific Immuno Oncology Assays Product Offered
  11.1.3 Thermo Fischer Scientific Immuno Oncology Assays Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Thermo Fischer Scientific Main Business Overview
  11.1.5 Thermo Fischer Scientific Latest Developments
11.2 Roche Diagnostics
  11.2.1 Roche Diagnostics Company Information
  11.2.2 Roche Diagnostics Immuno Oncology Assays Product Offered
  11.2.3 Roche Diagnostics Immuno Oncology Assays Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Roche Diagnostics Main Business Overview
  11.2.5 Roche Diagnostics Latest Developments
11.3 Agilent Technologies
  11.3.1 Agilent Technologies Company Information
  11.3.2 Agilent Technologies Immuno Oncology Assays Product Offered
  11.3.3 Agilent Technologies Immuno Oncology Assays Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Agilent Technologies Main Business Overview
  11.3.5 Agilent Technologies Latest Developments
11.4 Illumina
  11.4.1 Illumina Company Information
  11.4.2 Illumina Immuno Oncology Assays Product Offered
  11.4.3 Illumina Immuno Oncology Assays Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Illumina Main Business Overview
  11.4.5 Illumina Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Immuno Oncology Assays Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Immuno Oncology Assays Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunoassay
Table 4. Major Players of Flow Cytometry
Table 5. Major Players of PCR
Table 6. Major Players of Next Generation Sequencing
Table 7. Immuno Oncology Assays Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Immuno Oncology Assays Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Immuno Oncology Assays Market Size Market Share by Type (2020-2025)
Table 10. Immuno Oncology Assays Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Immuno Oncology Assays Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Immuno Oncology Assays Market Size Market Share by Application (2020-2025)
Table 13. Global Immuno Oncology Assays Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Immuno Oncology Assays Revenue Market Share by Player (2020-2025)
Table 15. Immuno Oncology Assays Key Players Head office and Products Offered
Table 16. Immuno Oncology Assays Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Immuno Oncology Assays Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Immuno Oncology Assays Market Size Market Share by Region (2020-2025)
Table 21. Global Immuno Oncology Assays Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Immuno Oncology Assays Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Immuno Oncology Assays Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Immuno Oncology Assays Market Size Market Share by Country (2020-2025)
Table 25. Americas Immuno Oncology Assays Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Immuno Oncology Assays Market Size Market Share by Type (2020-2025)
Table 27. Americas Immuno Oncology Assays Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Immuno Oncology Assays Market Size Market Share by Application (2020-2025)
Table 29. APAC Immuno Oncology Assays Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Immuno Oncology Assays Market Size Market Share by Region (2020-2025)
Table 31. APAC Immuno Oncology Assays Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Immuno Oncology Assays Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Immuno Oncology Assays Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Immuno Oncology Assays Market Size Market Share by Country (2020-2025)
Table 35. Europe Immuno Oncology Assays Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Immuno Oncology Assays Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Immuno Oncology Assays Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Immuno Oncology Assays Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Immuno Oncology Assays Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Immuno Oncology Assays
Table 41. Key Market Challenges & Risks of Immuno Oncology Assays
Table 42. Key Industry Trends of Immuno Oncology Assays
Table 43. Global Immuno Oncology Assays Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Immuno Oncology Assays Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Immuno Oncology Assays Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Immuno Oncology Assays Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Thermo Fischer Scientific Details, Company Type, Immuno Oncology Assays Area Served and Its Competitors
Table 48. Thermo Fischer Scientific Immuno Oncology Assays Product Offered
Table 49. Thermo Fischer Scientific Immuno Oncology Assays Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Thermo Fischer Scientific Main Business
Table 51. Thermo Fischer Scientific Latest Developments
Table 52. Roche Diagnostics Details, Company Type, Immuno Oncology Assays Area Served and Its Competitors
Table 53. Roche Diagnostics Immuno Oncology Assays Product Offered
Table 54. Roche Diagnostics Immuno Oncology Assays Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Roche Diagnostics Main Business
Table 56. Roche Diagnostics Latest Developments
Table 57. Agilent Technologies Details, Company Type, Immuno Oncology Assays Area Served and Its Competitors
Table 58. Agilent Technologies Immuno Oncology Assays Product Offered
Table 59. Agilent Technologies Immuno Oncology Assays Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Agilent Technologies Main Business
Table 61. Agilent Technologies Latest Developments
Table 62. Illumina Details, Company Type, Immuno Oncology Assays Area Served and Its Competitors
Table 63. Illumina Immuno Oncology Assays Product Offered
Table 64. Illumina Immuno Oncology Assays Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Illumina Main Business
Table 66. Illumina Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Immuno Oncology Assays Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Immuno Oncology Assays Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Immuno Oncology Assays Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Immuno Oncology Assays Sales Market Share by Country/Region (2024)
Figure 8. Immuno Oncology Assays Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Immuno Oncology Assays Market Size Market Share by Type in 2024
Figure 10. Immuno Oncology Assays in Research
Figure 11. Global Immuno Oncology Assays Market: Research (2020-2025) & ($ millions)
Figure 12. Immuno Oncology Assays in Clinical Diagnostics
Figure 13. Global Immuno Oncology Assays Market: Clinical Diagnostics (2020-2025) & ($ millions)
Figure 14. Global Immuno Oncology Assays Market Size Market Share by Application in 2024
Figure 15. Global Immuno Oncology Assays Revenue Market Share by Player in 2024
Figure 16. Global Immuno Oncology Assays Market Size Market Share by Region (2020-2025)
Figure 17. Americas Immuno Oncology Assays Market Size 2020-2025 ($ millions)
Figure 18. APAC Immuno Oncology Assays Market Size 2020-2025 ($ millions)
Figure 19. Europe Immuno Oncology Assays Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Immuno Oncology Assays Market Size 2020-2025 ($ millions)
Figure 21. Americas Immuno Oncology Assays Value Market Share by Country in 2024
Figure 22. United States Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Immuno Oncology Assays Market Size Market Share by Region in 2024
Figure 27. APAC Immuno Oncology Assays Market Size Market Share by Type (2020-2025)
Figure 28. APAC Immuno Oncology Assays Market Size Market Share by Application (2020-2025)
Figure 29. China Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 33. India Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Immuno Oncology Assays Market Size Market Share by Country in 2024
Figure 36. Europe Immuno Oncology Assays Market Size Market Share by Type (2020-2025)
Figure 37. Europe Immuno Oncology Assays Market Size Market Share by Application (2020-2025)
Figure 38. Germany Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 39. France Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Immuno Oncology Assays Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Immuno Oncology Assays Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Immuno Oncology Assays Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Immuno Oncology Assays Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 52. APAC Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 53. Europe Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 55. United States Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 56. Canada Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 57. Mexico Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 58. Brazil Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 59. China Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 60. Japan Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 61. Korea Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 63. India Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 64. Australia Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 65. Germany Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 66. France Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 67. UK Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 68. Italy Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 69. Russia Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 70. Egypt Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 71. South Africa Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 72. Israel Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 73. Turkey Immuno Oncology Assays Market Size 2026-2031 ($ millions)
Figure 74. Global Immuno Oncology Assays Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Immuno Oncology Assays Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Immuno Oncology Assays Market Size 2026-2031 ($ millions)